Journal ArticleOPEN ACCESS

A thrice-weekly ertapenem regimen is practical for hemodialysis patients

Antimicrobial Agents and Chemotherapy (2019) 63(12)
DOI: 10.1128/AAC.01427-19
7Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A change of ertapenem dosage from 500 mg daily to thrice weekly, after each hemodialysis session, can maintain the plasma concentration above 2 mg/liter and be practical for hemodialysis patients.

Author supplied keywords

Cite

CITATION STYLE

APA

Ueng, Y. F., Wang, H. J., Wu, S. C., & Ng, Y. Y. (2019). A thrice-weekly ertapenem regimen is practical for hemodialysis patients. Antimicrobial Agents and Chemotherapy, 63(12). https://doi.org/10.1128/AAC.01427-19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free